Greberman S B, Wada K
Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224.
Public Health Rep. 1994 Nov-Dec;109(6):731-7.
This article is an overview of social and legal differences in the United States and in Japan that are related to patterns of current drug abuse epidemics in these countries. These two nations have drug abuse problems with different histories and take different approaches currently to handling illicit drug marketing and use. Histories of opiate and cocaine abuse in the United States and of stimulant and inhalant abuse in Japan are discussed. The United States has experienced three heroin epidemics in the last three decades; cocaine addiction began to merit national concern by the end of the 1980s. In Japan, the first methamphetamine epidemic began after World War II; it was controlled in the 1950s. The current inhalant epidemic began in the late 1960s and was followed by the second methamphetamine epidemic that began in 1970; both are continuing to the present. The criminal justice system is always given first consideration when assessing societal measures employed to reduce drug use. Legal penalties for illicit drug offenses reflect the societal differences of these two nations with respect to the seriousness of particular types of crimes. Characteristics of the health care system of a nation may also influence patterns of drug abuse, particularly where functions of criminal justice and health care systems overlap. Health care systems in the United States and in Japan are based on different treatment philosophies and patients' expectations; these differences are discussed along with explanations of their potential influence on the epidemiology of drug abuse.
本文概述了美国和日本在社会及法律方面的差异,这些差异与这两个国家当前的药物滥用流行模式相关。这两个国家有着不同历史的药物滥用问题,且目前在处理非法药物销售和使用方面采取不同的方法。文中讨论了美国的阿片类药物和可卡因滥用历史以及日本的兴奋剂和吸入剂滥用历史。美国在过去三十年里经历了三次海洛因流行;到20世纪80年代末,可卡因成瘾开始引起全国关注。在日本,第一次甲基苯丙胺流行始于第二次世界大战后;在20世纪50年代得到控制。当前的吸入剂流行始于20世纪60年代末,随后是始于1970年的第二次甲基苯丙胺流行;两者至今仍在持续。在评估为减少药物使用而采取的社会措施时,刑事司法系统总是被优先考虑。对非法药物犯罪的法律处罚反映了这两个国家在特定类型犯罪严重性方面的社会差异。一个国家医疗保健系统的特点也可能影响药物滥用模式,特别是在刑事司法系统和医疗保健系统职能重叠的地方。美国和日本的医疗保健系统基于不同的治疗理念和患者期望;文中讨论了这些差异以及它们对药物滥用流行病学潜在影响的解释。